HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dzung H Dinh Selected Research

Glioblastoma (Glioblastoma Multiforme)

1/2021Retraction notice to "MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells" [Cellular Signaling (2012) 549-559].
7/2012Transcriptional repression of Mad-Max complex by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase in glioblastoma.
11/2010Downregulation of Focal Adhesion Kinase (FAK) by cord blood stem cells inhibits angiogenesis in glioblastoma.
9/2010Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
8/2010Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines.
4/2010Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.
6/2007Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis.
3/2007Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death.
12/2006SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
7/2005Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dzung H Dinh Research Topics

Disease

51Neoplasms (Cancer)
11/2020 - 08/2002
47Glioma (Gliomas)
04/2021 - 01/2002
21Glioblastoma (Glioblastoma Multiforme)
01/2021 - 11/2002
9Meningioma (Meningiomas)
02/2013 - 06/2006
6Neoplasm Metastasis (Metastasis)
12/2011 - 07/2006
5Medulloblastoma
12/2011 - 09/2010
4Spinal Cord Injuries (Spinal Cord Injury)
11/2011 - 01/2008
3Intervertebral Disc Degeneration
12/2019 - 12/2015
3Infections
03/2008 - 11/2002
3Brain Neoplasms (Brain Tumor)
06/2004 - 12/2002
2Low Back Pain (Lumbago)
01/2017 - 12/2015
2Pathologic Processes
10/2009 - 11/2002
1Deglutition Disorders (Dysphagia)
01/2020
1Back Pain (Backache)
01/2017
1Hyperemia
10/2015
1Spinal Subdural Hematoma
10/2015
1Subdural Hematoma (Subdural Hemorrhage)
10/2015
1Rupture
10/2015
1Edema (Dropsy)
04/2014
1Lipomatosis
09/2013
1Spinal Cord Diseases
09/2013
1Carcinogenesis
12/2011
1Hypoxia (Hypoxemia)
01/2011

Drug/Important Bio-Agent (IBA)

25Small Interfering RNA (siRNA)IBA
02/2013 - 05/2004
21Proteins (Proteins, Gene)FDA Link
02/2013 - 12/2002
20Urokinase Plasminogen Activator ReceptorsIBA
11/2020 - 01/2002
17Cathepsin BIBA
04/2021 - 12/2002
12Peptide Hydrolases (Proteases)FDA Link
01/2011 - 07/2003
12matrigelIBA
03/2008 - 11/2002
10Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2020 - 11/2002
7DNA (Deoxyribonucleic Acid)IBA
02/2013 - 07/2003
7Complementary DNA (cDNA)IBA
07/2011 - 11/2002
6Matrix Metalloproteinases (MMPs)IBA
01/2021 - 07/2003
6Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2013 - 11/2002
6Messenger RNA (mRNA)IBA
01/2011 - 07/2003
6tissue-factor-pathway inhibitor 2 (PP5)IBA
06/2007 - 01/2002
5IntegrinsIBA
07/2012 - 07/2010
5Thromboplastin (Tissue Factor)IBA
06/2007 - 01/2002
4Double-Stranded RNA (RNA, Double Stranded)IBA
11/2020 - 06/2004
4Cysteine Proteases (Cysteine Protease)IBA
10/2009 - 03/2004
3Dichlorodiphenyldichloroethane (DDD)IBA
12/2019 - 12/2015
3Plasminogen Activators (Plasminogen Activator)IBA
02/2013 - 06/2006
3Cysteine (L-Cysteine)FDA Link
02/2013 - 12/2006
3Cytochromes c (Cytochrome c)IBA
02/2012 - 01/2003
3Metalloproteases (Metalloproteinases)IBA
10/2011 - 06/2004
3Conditioned Culture MediaIBA
08/2011 - 03/2004
3Caspase 8 (Caspase-8)IBA
05/2010 - 10/2009
3CaspasesIBA
10/2008 - 01/2003
3EnzymesIBA
07/2007 - 11/2002
2CalcineurinIBA
04/2021 - 03/2012
2SteroidsIBA
04/2014 - 09/2013
2CateninsIBA
12/2011 - 10/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2011 - 03/2007
2angiogeninIBA
08/2011 - 08/2010
2Caspase 3 (Caspase-3)IBA
07/2010 - 12/2009
2Caspase 9IBA
07/2010 - 03/2004
2LuciferasesIBA
05/2010 - 01/2002
2Transcription Factors (Transcription Factor)IBA
12/2009 - 06/2003
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2009 - 03/2008
2Therapeutic UsesIBA
11/2008 - 03/2004
2EndopeptidasesIBA
03/2008 - 08/2002
2RNA (Ribonucleic Acid)IBA
07/2007 - 05/2004
2Protease Inhibitors (Protease Inhibitor)IBA
06/2007 - 12/2002
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
06/2003 - 01/2002
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2012
1U 0126 (UO 126)IBA
07/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2012
1Cyclin D1IBA
07/2012
1Oxygen (Dioxygen)IBA
02/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2012
1Glycoproteins (Glycoprotein)IBA
12/2011
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2011
1VimentinIBA
12/2011
1Cadherins (E-Cadherin)IBA
12/2011
1Notch ReceptorsIBA
10/2011
1ChemokinesIBA
08/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2011
1fluorescent protein 583IBA
07/2011
1NestinIBA
07/2011
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2011
1Bromodeoxyuridine (BrdU)IBA
01/2011
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2011
1Focal Adhesion Protein-Tyrosine KinasesIBA
11/2010
1PaxillinIBA
09/2010
1LipidsIBA
09/2010
1Death Domain ReceptorsIBA
09/2010
1CyclodextrinsIBA
09/2010
1Angiopoietin-1IBA
08/2010
1X-Linked Inhibitor of Apoptosis ProteinIBA
07/2010
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2010

Therapy/Procedure

20Therapeutics
12/2015 - 12/2002
7Radiotherapy
02/2013 - 01/2009
6Injections
06/2006 - 11/2002
2Total Disc Replacement
12/2019 - 12/2015
2Intraperitoneal Injections
08/2010 - 07/2007
2Drug Therapy (Chemotherapy)
10/2009 - 06/2007
1Operative Time
01/2020
1Diskectomy (Discectomy)
01/2020
1Spinal Fusion (Spondylosyndesis)
01/2017
1Vertebroplasty
10/2015